Acute Achilles tendon ruptures between 2002-2021: sustained increased incidence, surgical decline and prolonged delay to surgery-a nationwide study of 53 688 ruptures in Sweden.

key terms

Journal

BMJ open sport & exercise medicine
ISSN: 2055-7647
Titre abrégé: BMJ Open Sport Exerc Med
Pays: England
ID NLM: 101681007

Informations de publication

Date de publication:
2024
Historique:
accepted: 25 06 2024
medline: 23 7 2024
pubmed: 23 7 2024
entrez: 23 7 2024
Statut: epublish

Résumé

Given the lack of consensus on optimal treatment strategies for acute Achilles tendon rupture (ATR), understanding temporal trends, treatment choice and demographic characteristics is important. Previous research suggests increasing incidence with declining surgical treatment. Current trends in Sweden are not known. To assess how incidence rates, treatment trends and time from injury to surgery (TTS) of ATR have changed between 2002 and 2021 in Sweden, with particular attention to changes since 2012. Descriptive epidemiology study. We conducted a nationwide register-based study including all inpatients and outpatients ≥18 years of age with an ATR between 2002 and 2021 in Sweden. 53 688 ATRs (78.5% men) were identified during the study period. 15 045 patients (81.5% men) were surgically treated within 30 days. The long-term incidence rate for ATR injury increased by 45%, from 28.8 in 2002 to 41.7 in 2021 per 100 000 person-years (p<0.0001). In the last 5 years of the study, there was a significant, continuing increase in ATR incidence by 21%, from 34.4 in 2017 to 41.7 in 2021 per 100 000 person-years (p<0.0001). The surgical incidence rates decreased from 13.4 to 6.0 per 100 000 person-years (p<0.0001). TTS increased from 0.6 days in 2002 to 5.1 in 2021 (p<0.0001). The observed increase in incidence rates and decrease in surgical treatment of ATR emphasise the need for evidence-based treatment and rehabilitation protocols for non-operated patients of all ages. A significant increase in time from injury to surgery was observed throughout the study period.

Identifiants

pubmed: 39040046
doi: 10.1136/bmjsem-2024-001960
pii: bmjsem-2024-001960
pmc: PMC11261689
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e001960

Informations de copyright

Copyright © Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Simon Svedman (S)

Department of Orthopedics, Karolinska Universitetssjukhuset, Stockholm, Sweden.
Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Alejandro Marcano (A)

Department of Orthopedics, Karolinska Universitetssjukhuset, Stockholm, Sweden.
Department of Clinical Science Intervention and Technology, Division of Orthopaedics and Biotechnology, Karolinska Institutet, Stockholm, Sweden.

Paul W Ackermann (PW)

Department of Orthopedics, Karolinska Universitetssjukhuset, Stockholm, Sweden.
Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Li Felländer-Tsai (L)

Department of Clinical Science Intervention and Technology, Division of Orthopaedics and Biotechnology, Karolinska Institutet, Stockholm, Sweden.
Center for Advanced Medical Simulation and Training (CAMST), Karolinska University Hospital, Stockholm, Sweden.

Hans Erik Berg (HE)

Department of Orthopedics, Karolinska Universitetssjukhuset, Stockholm, Sweden.
Department of Clinical Science Intervention and Technology, Division of Orthopaedics and Biotechnology, Karolinska Institutet, Stockholm, Sweden.

Classifications MeSH